Hindustan Bio Sciences
7.35
+0.01(+0.14%)
Market Cap₹7.51 Cr
PE Ratio-36.70
Company Performance:
1D+0.14%
1M-15.61%
6M-5.41%
1Y-12.50%
5Y+96.52%
View Company Insightsright
More news about Hindustan Bio Sciences
19May 26
Hindustan Bio Sciences board meets on May 30 for FY26 results
Hindustan Bio Sciences Limited will hold a board meeting on May 30, 2026, to consider the audited financial results for the quarter and year ended March 31, 2026, along with the audit report for the fiscal year.
 no imag found
14Apr 26
Hindustan Bio Sciences Limited Reports No Dematerialization Activity in Q4 FY26
Hindustan Bio Sciences Limited filed its Q4 FY26 certificate under SEBI Regulation 74(5), confirming no equity shares were received for dematerialization from January 1 to March 31, 2026. The certificate, signed by Managing Director Venkata Rama Mohan Raju Jampana and verified by Registrar M/s. Venture Capital and Corporate Investments Pvt. Ltd., demonstrates regulatory compliance and stable shareholding patterns during the quarter.
 no imag found
02Feb 26
Hindustan Bio Sciences Completes Q3FY26 Results Publication in Newspapers
Hindustan Bio Sciences Limited has successfully published its Q3FY26 unaudited financial results in newspapers (Hitech Edition and Prajapalana) on February 1, 2026, complying with Regulation 47 of SEBI LODR. The company reported a profit of ₹8.20 lakhs for Q3FY26, marking a significant turnaround from previous quarter losses, with total income reaching ₹40.03 lakhs.
 no imag found
23Jan 26
Hindustan Bio Sciences Limited Reports Substantial Share Acquisition by Bosco Armando Menezes & Emily Bosco Menezes
Hindustan Bio Sciences Limited reported a substantial share acquisition by Bosco Armando Menezes and Emily Bosco Menezes under SEBI regulations. The non-promoter acquirers purchased 15,000 shares through open market transactions on January 22, 2026, increasing their combined holding from 4.98% to 5.12% of the company's voting capital. The company's equity structure remains unchanged at Rs.2,05,01,600 consisting of 1,02,50,800 shares of Rs.2 each.
 no imag found
31Jul 25
Hindustan Bio Sciences Reports Q1 Results, Appoints New Company Secretary
Hindustan Bio Sciences Ltd. reported Q1 FY2026 financial results with revenue from operations at Rs. 32.19 lakhs, down from previous periods but maintaining profitability at Rs. 1.40 lakhs. The company announced management changes with Mr. Devanshu Ravinder Dange resigning as Company Secretary and Mr. Shailendra Vyas appointed as the new Company Secretary, effective August 1. The board also approved various corporate governance matters including the notice for the 33rd AGM and adoption of the Secretarial Audit Report.
 no imag found
Hindustan Bio Sciences
7.35
+0.01
(+0.14%)
1 Year Returns:-12.50%
Industry Peers
Tanla Platforms
487.75
(-0.89%)
CE Info Systems
845.75
(-1.44%)
Moschip Technologies
198.03
(-1.60%)
TechNVision Ventures
3,763.50
(-5.00%)
Ramco Systems
546.25
(-1.51%)
Nucleus Software
646.95
(-0.51%)
Subex
19.34
(-1.98%)